Michael J. Rinaldi, MD
- Interventional Cardiology
- Cardiovascular Disease
Directions
About
Practicing Specialties
Clinical Interests
Languages
- English
Biography
Dr. Rinaldi is board certified in cardiology and specializes in interventional cardiology and vascular medicine. He is recognized as a national and international thought leader and an expert in the fields of coronary, peripheral and structural heart interventions, including transcatheter mitral valve repair and replacement, transcatheter aortic valve replacement, transcatheter tricuspid valve repair and left atrial appendage occlusion.
He is the medical director of the Structural Heart Program at Atrium Health Sanger Heart & Vascular Institute, a professor of medicine at the University of North Carolina and a faculty member of The International Andreas Gruentzig Society. He formerly served for a decade as the medical director of research of the Structural Heart Program.
Dr. Rinaldi has been recognized as a Top Doctor by the Charlotte Business Journal and Physician of the Quarter by Atrium Health Carolinas Medical Center. He is a member of the Alpha Omega Alpha Honor Medical Society.
As the medical director of research at Sanger Heart & Vascular Institute for 10 years, he has served as a principal or sub investigator for numerous clinical trials involving thousands of patients. His current research interests include transcatheter mitral, aortic, tricuspid valve therapies, including novel devices and techniques through clinical trials and research.
Dr. Rinaldi has authored or co-authored more than 75 publications and 100 abstracts in journals such as the New England Journal of Medicine, the Lancet, the Journals of the American College of Cardiology and Circulation. He has presented over 200 invited lectures nationally and internationally and has served on the faculty at most major cardiovascular conferences in the US.
He received his medical degree at Cornell University and completed his residency at Harvard University. He followed that with fellowships at Harvard University and Tufts University. Additionally, he completed a course in clinical effectiveness at Harvard University.